Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies
Clinical trial NCT01625338 · COMPLETED
Trial details
- NCT number
- NCT01625338
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2014-10-01
- Enrollment
- 534
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.